CIBC World Markets Inc. acquired a new stake in TESARO Inc (NASDAQ:TSRO) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 9,300 shares of the biopharmaceutical company’s stock, valued at approximately $771,000.

A number of other institutional investors and hedge funds have also modified their holdings of TSRO. Exane Derivatives purchased a new position in shares of TESARO in the third quarter valued at approximately $106,000. Nordea Investment Management AB purchased a new position in shares of TESARO in the second quarter valued at approximately $167,000. Toronto Dominion Bank lifted its position in shares of TESARO by 244.6% in the third quarter. Toronto Dominion Bank now owns 1,592 shares of the biopharmaceutical company’s stock valued at $206,000 after acquiring an additional 1,130 shares in the last quarter. Achmea Investment Management B.V. purchased a new position in shares of TESARO in the second quarter valued at approximately $234,000. Finally, Commonwealth Equity Services Inc purchased a new position in shares of TESARO in the third quarter valued at approximately $222,000.

In related news, SVP Martin H. Jr. Huber sold 829 shares of TESARO stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $85.24, for a total transaction of $70,663.96. Following the transaction, the senior vice president now owns 8,101 shares in the company, valued at $690,529.24. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 34.60% of the company’s stock.

Several research firms have recently weighed in on TSRO. BidaskClub upgraded TESARO from a “strong sell” rating to a “sell” rating in a research report on Tuesday, January 23rd. Piper Jaffray Companies restated a “hold” rating and issued a $65.00 target price on shares of TESARO in a research report on Thursday, January 18th. Credit Suisse Group restated an “outperform” rating and issued a $150.00 target price (down previously from $190.00) on shares of TESARO in a research report on Thursday, January 18th. Morgan Stanley decreased their target price on TESARO from $165.00 to $156.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 16th. Finally, HC Wainwright restated a “buy” rating and issued a $158.00 target price on shares of TESARO in a research report on Friday, January 12th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. TESARO presently has an average rating of “Hold” and an average target price of $149.97.

TESARO Inc (NASDAQ TSRO) opened at $58.17 on Thursday. TESARO Inc has a 1 year low of $57.81 and a 1 year high of $192.94. The company has a market capitalization of $3,160.00, a P/E ratio of -6.90 and a beta of 1.25. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.35 and a current ratio of 4.73.

TRADEMARK VIOLATION NOTICE: “CIBC World Markets Inc. Acquires Shares of 9,300 TESARO Inc (TSRO)” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2018/02/08/cibc-world-markets-inc-acquires-shares-of-9300-tesaro-inc-tsro.html.

TESARO Company Profile

TESARO, Inc is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.

Want to see what other hedge funds are holding TSRO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TESARO Inc (NASDAQ:TSRO).

Institutional Ownership by Quarter for TESARO (NASDAQ:TSRO)

Receive News & Ratings for TESARO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TESARO and related companies with MarketBeat.com's FREE daily email newsletter.